Related Experiment Video
Updated: Oct 2, 2025
10:29
Generation of Human Chimeric Antigen Receptor Regulatory T Cells
Published on: January 3, 2025
1.6K
CAR-T Regulatory (CAR-Treg) Cells: Engineering and Applications
Motahareh Arjomandnejad1, Acadia L Kopec1, Allison M Keeler1,2,3
1Horae Gene Therapy Center, University of Massachusetts Chan Medical School, Worcester, MA 01655, USA.
Biomedicines
|February 25, 2022
Summary
Engineered chimeric antigen receptor (CAR) T regulatory cells (Tregs) offer enhanced immune suppression for autoimmune diseases and transplantation. Further research is needed to optimize CAR Treg therapy for broader clinical use.
Area of Science:
- Immunology
- Cell Therapy
- Transplantation
Background:
- Regulatory T cells (Tregs) are crucial for immune tolerance but have limitations in antigen recognition for therapeutic applications.
- Polyclonal Tregs exhibit non-specific antigen recognition, hindering their efficacy in clinical settings for autoimmune diseases and organ transplantation.
- Engineering Tregs with chimeric antigen receptors (CARs) can confer antigen specificity and enhance their therapeutic potential.
Purpose of the Study:
- To review the recent advancements and therapeutic applications of CAR Tregs in modulating immune responses.
- To highlight the advantages of CAR Tregs over polyclonal Tregs in autoimmune diseases and transplantation.
- To identify areas for future development in CAR Treg engineering for improved efficacy and safety.
Main Methods:
- Review of recent scientific literature on CAR T regulatory cells.
- Analysis of studies investigating CAR Treg function in autoimmune diseases and transplantation models.
- Comparison of CAR Tregs with T-cell receptor (TCR) engineered Tregs and polyclonal Tregs.
Main Results:
- CAR Tregs demonstrate MHC-independent and IL-2-independent function, maintaining Treg phenotype and enhancing suppressive efficacy.
- Engineered CAR Tregs show improved homing to target tissues compared to polyclonal Tregs.
- CAR Tregs present a promising strategy for modulating immune responses in various therapeutic contexts.
Conclusions:
- CAR Tregs represent a significant advancement in cell therapy for immune-mediated diseases and transplantation.
- Further optimization is required to enhance CAR Treg suppressive function, stability, and safety for clinical translation.
- Continued research into CAR Treg biology and clinical application is essential for realizing their full therapeutic potential.
